KLRS · Kalaris Therapeutics, Inc.
$4.10
+0.02 (+0.49%)
At close · Aug 27
Market Cap
$99.98M
Shares
23.80M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-04-03 | — | $100,000,000 | — | — | 10-Q , filed 2026-08-11 |
Key facts
CIK
1754068
CUSIP
482929106
13F (30d)
55 filings
55 filers
Visit website
Investor relations